Lorenz Thurner

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · The Lancet · 2019 · 244 citations · Full text

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · Leukemia · 2022 · 146 citations · Full text

Neuro-oncology, Lymphoid Neoplasia, Transplantation +9

Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma

Sylvia Hartmann, Bianca Schuhmacher, Tobias Rausch et al. · Leukemia · 2015 · 98 citations

Tumor Biology, Lymphoid Neoplasia, Medicine +7

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study

Jochen Pfeifer, Bernhard Thurner, Christoph Kessel et al. · The Lancet Rheumatology · 2022 · 65 citations · Full text

Inflammation, Rheumatology, Multisystem Inflammatory Syndrome +15

<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma

Bianca Schuhmacher, Julia Bein, Tobias Rausch et al. · Haematologica · 2018 · 64 citations · Full text